A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 9 April 2023) has been published and includes articles on:
Isotretinoin (Roaccutane▼): new safety measures to be introduced in the coming months.
Janus kinase (JAK) inhibitors: new measures to reduce risks of major cardiovascular eventss, malignancy, venous thromboembolism, serious infections and increased mortality.
Nitrofurantoin: reminder of the risks of pulmonary and hepatic adverse drug reactions.
Letters and medicine recalls sent to healthcare professionals in March 2023.
To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.